In addition, supplementation with Akkermansia muciniphila has been associated with improved insulin sensitivity and reductions in liver inflammation and dysfunction [267], underscoring the potential for non-pharmacologic, microbiome-targeted therapies in comprehensive T2D management. The gene discussed is INS; the disease is type 2 diabetes mellitus.